 |
| 8:00 - 9:00am |
Registration and Vendor Exhibits
|
|
| 9:00 - 9:05am |
Welcome Remarks
Janet Xiao, CABS President-Elect, Partner, Morrison & Foerster LLP
|
|
| 9:05 - 9:15am |
State of the Society
Wei Dong, CABS President, Global Biometrics Head Asia Pacific, Roche |
|
| |
Session I: Emerging Trends in the Biopharmaceutical Industry
Session Chairs: Cheni Kwok and Shichang Miao
|
| 9:15 - 9:40am |
Douglass Given, Investment Partner, Managing Director and Founder, Bay City Capital
"Emerging Trends in the Biopharmaceutical Industry" |
| 9:40 - 10.05am |
John Oyler, Founder and CEO of BeiGene, China
"New Paradigms for Biopharmaceutical Research and Development in China" |
| 10:05 - 10.30am |
Don Ganem VP and Global Head of Infectious Disease, Novartis Institutes of Biomedical Research |
| 10:30 - 10:50am |
Chuck Comey, Partner, Morrison & Foerster LLP, Platinum Sponsor |
|
| 10:50 - 11:10am |
Break, Networking, and Vendor Exhibits |
|
| |
Session II: New Waves of Drug Discovery and Commercialization
Session Chairs: Charlene Liao and John Mao
|
| 11:10 - 11:35am |
Napoleone Ferrara, Genentech Fellow, Genentech
"New Insights into the Regulation of Angiogenesis" |
| 11:35 - 12:00am |
Neil Desai, Senior VP, Abraxis BioScience LLC, Celgene
"Nanotechnology from Bench to the Clinic and Beyond" |
| 12:00 - 12:25pm |
Stephen K. Doberstein, Senior VP and Chief Scientific Officer, Nektar Therapeuticsh
"New Promises with Polymer-Drug Conjugates" |
| 12:25 - 12:35pm |
Connie Sun, Senior VP of Oncology Chemistry, Pharmaron, Gold Sponsor |
| 12:35 - 12:45pm |
Jun Li, Chief Scientific Officer, Abgent, Gold Sponsor |
|
| 12:45 - 1:45pm |
Lunch |
|
| |
Session III: Global Clinical Development and Product Registration
Session Chairs: Wei Dong, Josh Xiao and Charles Liu
|
| 1:45 - 2:10pm |
Frank Shen, Divisional VP of Global Data Management and Statistics, Pharmaceutical R&D, Abbott Laboratories
"A Bridge Too Far? Challenges and Opportunities in Linking China into Simultaneous Global Development via Multi-Regional Clinical Trials" |
| 2:10 - 2:35pm |
Albert Liou, Vice President and General Manager, PAREXEL International
"Prospect of Global Clinical Development Next 10 Years: Asia's Roles" |
| 2:35 - 3:00pm |
Wen Chen, VP of Business Development, TigerMed Consulting, China |
| 3:00 - 3:10pm |
Cassandra Boyer, Regional Sales Director, GE Healthcare, Gold Sponsor |
| 3:10 - 3:20pm |
Hui Li, Director of Business Development, PPD/BioDuro, Gold Sponsor |
|
| 3:20 - 3:40pm |
Break, Networking, and Vendor Exhibits |
|
| |
Session IV: China's Future in Life Sciences: New Drivers of Innovation
Session Chairs: Chi-Hui Tang and Alan Hao
|
| 3:40 - 4:00pm |
Michael Zielenziger, Consultant, Monitor Group
"China's Future in Life Sciences: New Drivers of Innovation" |
| 4:00 - 4:20pm |
Sofie Qiao, President, CEO and Co-Founder, LINQ Pharmaceuticals
"A Nuanced Balance" |
| 4:20 - 4:40pm |
Xiaodong Yang, President and CEO, Apexigen
"Managing Strategic Alliances with Partners in China: Apexigen's Experience" |
| 4:40 - 5:00pm |
Reinhard Oesterle, Senior Director of Business Development, SciClone Pharmaceuticals
"Building a Leading Specialty Pharma Company in China" |
| 5:00 - 5:10pm |
Peter Zhang, CEO, GenePharma, Gold Sponsor |
| 5:10 - 5:40pm |
Panel Discussion |
|
| 5:40 - 6:00pm |
Break, Networking, and Vendor Exhibits |
|
| 6:00 - 7:00pm |
Dinner |
|
| |
Session V: Crossing the Bridge: Opportunities and Lessons Learned
Session Chairs: Hua Tu and Yibing Wang
|
| 7:00 - 7:15pm |
Joy Zhu, Senior VP of Global Clinical Development, S*BIO, Singapore
"Leveraging Geographic Location and Development Talent in Drug Developmet - A S*BIO Story" |
| 7:15 - 7:30pm |
Joyce Peng, Marketing Director, BGI Americas Corporation
"Partnering for Multi-omics Excellence" |
| 7:30 - 7:45pm |
Andrew Wong, Director of Corporate Development, Alexza Pharmaceuticals, Inc.
"Efficient Creation of Differentiated Therapies-Alexza Pharmaceuticals & the Staccato System" |
| 7:45 - 8:00pm |
Dongxiao Zhang, President and CEO, Formurex
"Channeling the New Wave of Chinese Pharmaceutical Products to the US Market" |
| 8:00 - 8:15pm |
John Wang, President and CEO, ImmuOn, China
"China: The Road to Home" |
| 8:15 - 8:30pm |
Hua Tu, President and CEO, LakePharma, Inc.
"Large Molecule Drug Development in China" |
| 8:30 - 9:00pm |
Panel Discussion |
|
| 9:00pm |
Adjourned |
